MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 45 filers reported holding MARRONE BIO INNOVATIONS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,000 | – | 947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 11,781,942 | $14,733,000 | 3.30% |
| ICM ASSET MANAGEMENT INC/WA | 252,900 | $357,000 | 0.28% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 504,298 | $711,000 | 0.10% |
| WADDELL & REED FINANCIAL INC | 24,714,892 | $34,848,000 | 0.09% |
| Fairpointe Capital LLC | 415,400 | $586,000 | 0.03% |
| Claraphi Advisory Network, LLC | 14,863 | $21,000 | 0.01% |
| Spark Investment Management LLC | 62,200 | $87,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,350,600 | $3,314,000 | 0.00% |
| Allworth Financial LP | 11,266 | $16,000 | 0.00% |
| A.R.T. Advisors, LLC | 11,529 | $16,000 | 0.00% |